ANDA 61725, held by Warner Chilcott. Tetracycline Hydrochloride.
As of Nov 16, 2026, ANDA 61725 (Cyclopar), held by Warner Chilcott, was first approved by FDA on Jun 8, 1973, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 8, 1973 | Original application | Approved | None posted |
| Cyclopar250MG · capsule;oral | Tetracycline Hydrochloride | Discontinued |
| Cyclopar500MG · capsule;oral | Tetracycline Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters